Answers are grounded in this paper and cite their sources.
A murine monoclonal antibody directed at the platelet glycoprotein IIb/IIIa complex, which blocks platelet aggregation ex vivo, was tested for its antithrombotic effects in an established animal model of acute platelet thrombus formation in partially stenosed arteries. Infusion of 0.7 to 0.8 mg/kg of the F(ab')2 fragment of the antibody completely blocked new thrombus formation despite multiple provocations, making it the most potent antithrombotic agent tested in this model.
No takes yet. Share an insight, caveat, or question.
Coller et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: